Synergistic in vitro anti-tumor effect of letrozole and everolimus on human endometrial carcinoma Ishikawa cells.
To investigate the in vitro effect of the use of combination of letrozole and everolimus on the proliferation and apoptosis of human endometrial carcinoma Ishikawa cells. Different concentrations of letrozole alone or in combination with everolimus were added to Ishikawa cell cultures in vitro. Cell viability was assessed using MTT assay. Double staining with Annexin-V-FITC was used to detect the cell apoptosis by the flow cytometry (FCM). The expression of PTEN and 4E-BP1 proteins was analyzed with Western blotting. Letrozole by itself inhibited cell viability and decreased the invasiveness of Ishikawa cells. The anti-tumor effect of letrozole in combination with everolimus was improved compared to letrozole alone. Letrozole and everolimus synergistically inhibit the proliferation and induce cell apoptosis by inhibiting the cell signal pathway PI3K/Akt/mTOR and inducing cell apoptosis, thus showing a promising anti-tumor effectiveness.